Variability of plasma fluconazole levels in patients with hematologic malignancy.
作者信息
Ellis M E, Spence D, Ernst P, Greer W
机构信息
Department of Medicine, HCI International Medical Centre, Clydebank, Scotland.
出版信息
Clin Infect Dis. 1997 Jan;24(1):86-7. doi: 10.1093/clinids/24.1.86.
PMID:8994774
Abstract
摘要
相似文献
1
Variability of plasma fluconazole levels in patients with hematologic malignancy.血液系统恶性肿瘤患者血浆氟康唑水平的变异性。
Clin Infect Dis. 1997 Jan;24(1):86-7. doi: 10.1093/clinids/24.1.86.
2
Serum levels of fluconazole in patients after cytotoxic chemotherapy for hematological malignancy.
Am J Hematol. 2001 Feb;66(2):85-91. doi: 10.1002/1096-8652(200102)66:2<85::AID-AJH1022>3.0.CO;2-M.
3
Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.氟康唑在浅表和全身性真菌病中的临床药代动力学
Clin Pharmacokinet. 1997 Jul;33(1):52-77. doi: 10.2165/00003088-199733010-00005.
4
[Level of evidence for therapeutic drug monitoring of fluconazole].[氟康唑治疗药物监测的证据级别]
Therapie. 2011 Mar-Apr;66(2):97-101. doi: 10.2515/therapie/2011013. Epub 2011 Jun 6.
5
[Pharmacokinetics and dosage of fluconazole in continuous hemofiltration (CAVH, CVVH) and hemodialysis (CAVHD, CVVHD)].
Mycoses. 1998;41 Suppl 2:86-8. doi: 10.1111/j.1439-0507.1998.tb00610.x.
6
Fluconazole.
Pediatr Rev. 2006 Apr;27(4):158-9. doi: 10.1542/pir.27-4-158.
7
In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy.在荟萃分析中，在治疗血液系统恶性肿瘤时，伊曲康唑在预防系统性真菌感染方面优于氟康唑。
Br J Haematol. 2006 Mar;132(5):656-8; author reply 658-9. doi: 10.1111/j.1365-2141.2006.05967.x.
8
Antifungal prophylaxis and therapy in patients with hematological malignancies and hematopoietic stem cell transplant recipients.血液病患者和造血干细胞移植受者的抗真菌预防和治疗。
Expert Rev Anti Infect Ther. 2010 Dec;8(12):1451-66. doi: 10.1586/eri.10.141.
9
Population pharmacokinetics of fluconazole after administration of fosfluconazole and fluconazole in critically ill patients.重症患者使用伏立康唑和氟康唑给药后的氟康唑群体药代动力学。
J Clin Pharm Ther. 2012 Jun;37(3):356-63. doi: 10.1111/j.1365-2710.2011.01297.x. Epub 2011 Aug 24.
10
[Current Status and Future Perspectives of Primary Antifungal Prophylaxis in Patients with Hematological Malignancies-Review].[血液系统恶性肿瘤患者原发性抗真菌预防的现状与未来展望——综述]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Apr;25(2):627-632. doi: 10.7534/j.issn.1009-2137.2017.02.059.
引用本文的文献
1
Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.氟康唑在浅表和全身性真菌病中的临床药代动力学
Clin Pharmacokinet. 1997 Jul;33(1):52-77. doi: 10.2165/00003088-199733010-00005.
Zotero 插件